CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells

Cyclin dependent kinase 11 (CDK11) is a protein kinase that regulates RNA transcription, pre-mRNA splicing, mitosis, and cell death. Targeting of CDK11 expression levels is effective in the experimental treatment of breast and other cancers, but these data are lacking in melanoma. To understand CDK1...

Full description

Bibliographic Details
Main Authors: Rehana L. Ahmed, Daniel P. Shaughnessy, Todd P. Knutson, Rachel I. Vogel, Khalil Ahmed, Betsy T. Kren, Janeen H. Trembley
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/12/2/50
_version_ 1831657882642284544
author Rehana L. Ahmed
Daniel P. Shaughnessy
Todd P. Knutson
Rachel I. Vogel
Khalil Ahmed
Betsy T. Kren
Janeen H. Trembley
author_facet Rehana L. Ahmed
Daniel P. Shaughnessy
Todd P. Knutson
Rachel I. Vogel
Khalil Ahmed
Betsy T. Kren
Janeen H. Trembley
author_sort Rehana L. Ahmed
collection DOAJ
description Cyclin dependent kinase 11 (CDK11) is a protein kinase that regulates RNA transcription, pre-mRNA splicing, mitosis, and cell death. Targeting of CDK11 expression levels is effective in the experimental treatment of breast and other cancers, but these data are lacking in melanoma. To understand CDK11 function in melanoma, we evaluated protein and RNA levels of CDK11, Cyclin L1 and Cyclin L2 in benign melanocytes and BRAF- as well as NRAS-mutant melanoma cell lines. We investigated the effectiveness of reducing expression of this survival kinase using RNA interference on viability, clonal survival, and tumorsphere formation in melanoma cell lines. We examined the impact of CDK11 loss in BRAF-mutant melanoma on more than 700 genes important in cancer signaling pathways. Follow-up analysis evaluated how CDK11 loss alters cell cycle function in BRAF- and NRAS-mutant melanoma cells. We present data on CDK11, CCNL1 and CCNL2 mRNA expression in melanoma patients, including prognosis for survival. In sum, we found that CDK11 is necessary for melanoma cell survival, and a major impact of CDK11 loss in melanoma is to cause disruption of the cell cycle distribution with accumulation of G1- and loss of G2/M-phase cancer cells.
first_indexed 2024-12-19T17:34:47Z
format Article
id doaj.art-c36cf854d71c4daca8db8a3ed125a87d
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-12-19T17:34:47Z
publishDate 2019-04-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-c36cf854d71c4daca8db8a3ed125a87d2022-12-21T20:12:21ZengMDPI AGPharmaceuticals1424-82472019-04-011225010.3390/ph12020050ph12020050CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma CellsRehana L. Ahmed0Daniel P. Shaughnessy1Todd P. Knutson2Rachel I. Vogel3Khalil Ahmed4Betsy T. Kren5Janeen H. Trembley6Department of Dermatology, University of Minnesota, Minneapolis, MN 55455, USAResearch Service, Minneapolis VA Health Care System, Minneapolis, MN 55417, USADepartment of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USAMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USACyclin dependent kinase 11 (CDK11) is a protein kinase that regulates RNA transcription, pre-mRNA splicing, mitosis, and cell death. Targeting of CDK11 expression levels is effective in the experimental treatment of breast and other cancers, but these data are lacking in melanoma. To understand CDK11 function in melanoma, we evaluated protein and RNA levels of CDK11, Cyclin L1 and Cyclin L2 in benign melanocytes and BRAF- as well as NRAS-mutant melanoma cell lines. We investigated the effectiveness of reducing expression of this survival kinase using RNA interference on viability, clonal survival, and tumorsphere formation in melanoma cell lines. We examined the impact of CDK11 loss in BRAF-mutant melanoma on more than 700 genes important in cancer signaling pathways. Follow-up analysis evaluated how CDK11 loss alters cell cycle function in BRAF- and NRAS-mutant melanoma cells. We present data on CDK11, CCNL1 and CCNL2 mRNA expression in melanoma patients, including prognosis for survival. In sum, we found that CDK11 is necessary for melanoma cell survival, and a major impact of CDK11 loss in melanoma is to cause disruption of the cell cycle distribution with accumulation of G1- and loss of G2/M-phase cancer cells.https://www.mdpi.com/1424-8247/12/2/50CDK11Cyclin L1Cyclin L2cell cyclecancermelanoma
spellingShingle Rehana L. Ahmed
Daniel P. Shaughnessy
Todd P. Knutson
Rachel I. Vogel
Khalil Ahmed
Betsy T. Kren
Janeen H. Trembley
CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
Pharmaceuticals
CDK11
Cyclin L1
Cyclin L2
cell cycle
cancer
melanoma
title CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
title_full CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
title_fullStr CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
title_full_unstemmed CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
title_short CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells
title_sort cdk11 loss induces cell cycle dysfunction and death of braf and nras melanoma cells
topic CDK11
Cyclin L1
Cyclin L2
cell cycle
cancer
melanoma
url https://www.mdpi.com/1424-8247/12/2/50
work_keys_str_mv AT rehanalahmed cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT danielpshaughnessy cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT toddpknutson cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT rachelivogel cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT khalilahmed cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT betsytkren cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells
AT janeenhtrembley cdk11lossinducescellcycledysfunctionanddeathofbrafandnrasmelanomacells